Literature DB >> 7754678

The methyltransferase inhibitor Neplanocin A interferes with influenza virus replication by a mechanism different from that of 3-deazaadenosine.

P Woyciniuk1, M Linder, C Scholtissek.   

Abstract

Neplanocin A (NeplA) and 3-deazaadenosine (3DA-Ado) are both inhibitors of methyltransferases, and both interfere with influenza virus replication. Their modes of action, however, are different. In chicken embryo cells NeplA inhibits only in media depleted of or low in methionine, while 3DA-Ado acts independently of the concentration of methionine. While homocysteine partially reverses the effect of NeplA, it strongly potentiates the effect of 3DA-Ado. While NeplA inhibits the synthesis of all viral proteins to nearly the same extent, 3DA-Ado interferes only with the production of late proteins (Fischer et al. (1990) Virology 177, 523-531). In NeplA-pretreated cells there is an extreme accumulation of S-adenosylhomocysteine, independent of the concentration of methionine in the medium, although NeplA inhibits influenza virus replication only in methionine-depleted medium. Therefore an accumulation of this intermediate by NeplA cannot account for the inhibitory effect, as has been implicated in the inhibition of the replication of other viruses. Our results indicate that at least two different methyltransferases are involved in influenza virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7754678     DOI: 10.1016/0168-1702(94)00085-q

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.

Authors:  Yi Wang; Ying Sun; Andong Wu; Shan Xu; Ruangang Pan; Cong Zeng; Xu Jin; Xingyi Ge; Zhengli Shi; Tero Ahola; Yu Chen; Deyin Guo
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity.

Authors:  Etienne Decroly; Isabelle Imbert; Bruno Coutard; Mickaël Bouvet; Barbara Selisko; Karine Alvarez; Alexander E Gorbalenya; Eric J Snijder; Bruno Canard
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

Review 3.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

Review 4.  Recent Advances Towards the Development of a Potent Antiviral Against the Hepatitis E Virus.

Authors:  Saumya Anang; Nidhi Kaushik; Milan Surjit
Journal:  J Clin Transl Hepatol       Date:  2018-06-28

Review 5.  Molecular mechanisms of coronavirus RNA capping and methylation.

Authors:  Yu Chen; Deyin Guo
Journal:  Virol Sin       Date:  2016-02-02       Impact factor: 4.327

6.  Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase.

Authors:  Ying Sun; Zidao Wang; Jiali Tao; Yi Wang; Andong Wu; Ziwen Yang; Kaimei Wang; Liqiao Shi; Yu Chen; Deyin Guo
Journal:  Antiviral Res       Date:  2014-02-11       Impact factor: 5.970

7.  mRNA cap-1 methyltransferase in the SARS genome.

Authors:  Marcin von Grotthuss; Lucjan S Wyrwicz; Leszek Rychlewski
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.